Intec pharma ltd. (NTEC)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES:
NET LOSS

-40,813

-47,599

-53,646

-42,446

-43,470

-43,543

0

0

0

Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation

942

854

863

874

871

859

0

0

0

Exchange differences on cash and cash equivalents

194

67

1,426

1,178

877

829

0

0

0

Change in right of use asset

930

967

0

0

0

-

-

-

-

Change in lease liabilities

767

713

0

0

0

-

-

-

-

Gains on marketable securities

0

-

-

-

-

-194

0

0

0

Share-based compensation

2,720

3,221

3,523

3,587

3,447

3,227

0

0

0

Changes in operating assets and liabilities:
Decrease in prepaid expenses and other receivables

0

-

-

-

0

-

-

-

-

Increase in prepaid expenses and other receivables

-

-

-

-

-

-

-

0

0

Increase in deferred tax assets

-

-281

0

0

0

-

-

-

-

Increase (decrease) in accounts payable and accruals

0

-

-

0

0

-

-

0

0

Increase in other liabilities

267

295

0

0

0

-

-

-

-

Net cash used in operating activities

-26,930

-29,045

-32,045

-36,948

-36,083

-39,076

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment

914

921

2,826

2,205

2,655

4,667

0

0

0

Investment in other assets

-

2,865

0

0

0

-

-

-

-

Proceeds from disposal of marketable securities, net

772

576

912

873

828

298

0

0

0

Net cash (used in) provided by investing activities

-1,801

-3,210

-6,711

-6,003

-7,965

-9,301

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of ordinary shares, net of issuance costs

0

-

-

-

-

-

-

-

-

Proceeds from issuance of ordinary shares and warrants, net of issuance costs

0

-

-

-

-

-

-

-

-

Proceeds from exercise of options

-

282

0

0

0

-

-

-

-

Net cash provided by financing activities

8,320

2,368

0

0

0

-

-

-

-

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

0

-

0

0

0

-

0

0

0

EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS

-194

-67

-1,426

-1,178

-877

-829

0

0

0

SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Liability with respect to property and equipment

-

-

0

0

0

-

-

-

-

Liability with respect to other assets (see note 4a)

-

-

0

0

0

-

-

-

-

Receivables with respect to exercise of options

-

-

-

-

0

-

-

-

-

SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION -
Interest received

208

327

527

788

745

734

0

0

0